These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 25704103

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Quantitative RT-PCR analysis of estrogen receptor gene expression in laser microdissected prostate cancer tissue.
    Walton TJ, Li G, McCulloch TA, Seth R, Powe DG, Bishop MC, Rees RC.
    Prostate; 2009 Jun 01; 69(8):810-9. PubMed ID: 19189301
    [Abstract] [Full Text] [Related]

  • 5. The endocrine-gland-derived vascular endothelial growth factor (EG-VEGF)/prokineticin 1 and 2 and receptor expression in human prostate: Up-regulation of EG-VEGF/prokineticin 1 with malignancy.
    Pasquali D, Rossi V, Staibano S, De Rosa G, Chieffi P, Prezioso D, Mirone V, Mascolo M, Tramontano D, Bellastella A, Sinisi AA.
    Endocrinology; 2006 Sep 01; 147(9):4245-51. PubMed ID: 16763065
    [Abstract] [Full Text] [Related]

  • 6. The prostate cancer-up-regulated long noncoding RNA PlncRNA-1 modulates apoptosis and proliferation through reciprocal regulation of androgen receptor.
    Cui Z, Ren S, Lu J, Wang F, Xu W, Sun Y, Wei M, Chen J, Gao X, Xu C, Mao JH, Sun Y.
    Urol Oncol; 2013 Oct 01; 31(7):1117-23. PubMed ID: 22264502
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Targeting the A3 adenosine receptor for cancer therapy: inhibition of prostate carcinoma cell growth by A3AR agonist.
    Fishman P, Bar-Yehuda S, Ardon E, Rath-Wolfson L, Barrer F, Ochaion A, Madi L.
    Anticancer Res; 2003 Oct 01; 23(3A):2077-83. PubMed ID: 12894581
    [Abstract] [Full Text] [Related]

  • 10. Identification of adenosine receptor subtypes expressed in the human endothelial-like ECV304 cells.
    Kobayashi R, Saitoh O, Nakata H.
    Pharmacology; 2005 Jun 01; 74(3):143-51. PubMed ID: 15795521
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Tissue distribution of adenosine receptor mRNAs in the rat.
    Dixon AK, Gubitz AK, Sirinathsinghji DJ, Richardson PJ, Freeman TC.
    Br J Pharmacol; 1996 Jul 01; 118(6):1461-8. PubMed ID: 8832073
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Differential gene expression of adenosine A1, A2a, A2b, and A3 receptors in the human enteric nervous system.
    Christofi FL, Zhang H, Yu JG, Guzman J, Xue J, Kim M, Wang YZ, Cooke HJ.
    J Comp Neurol; 2001 Oct 08; 439(1):46-64. PubMed ID: 11579381
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Androgen receptor as a regulator of ZEB2 expression and its implications in epithelial-to-mesenchymal transition in prostate cancer.
    Jacob S, Nayak S, Fernandes G, Barai RS, Menon S, Chaudhari UK, Kholkute SD, Sachdeva G.
    Endocr Relat Cancer; 2014 Jun 08; 21(3):473-86. PubMed ID: 24812058
    [Abstract] [Full Text] [Related]

  • 17. Expression of A1 and A3 adenosine receptors in human breast tumors.
    Panjehpour M, Hemati S, Forghani MA.
    Tumori; 2012 Jun 08; 98(1):137-41. PubMed ID: 22495714
    [Abstract] [Full Text] [Related]

  • 18. Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression.
    Sun A, Tang J, Hong Y, Song J, Terranova PF, Thrasher JB, Svojanovsky S, Wang HG, Li B.
    Prostate; 2008 Mar 01; 68(4):453-61. PubMed ID: 18196538
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.